Activation of NK cells by an endocytosed receptor for soluble HLA-G

PLoS Biology

Volumn 4, Issue 1, 2006, Pages 0070-0086

  Rajagopalan, Sumati ^a   Bryceson, Yenan T ^a   Kuppusamy, Shanmuga P ^a   Geraghty, Daniel E ^b   Van Der Meer, Arnold ^c   Joosten, Irma ^c   Long, Eric O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; DYNAMIN; HLA G ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; LYMPHOCYTE ANTIGEN RECEPTOR; RAB PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; CELL COMPARTMENTALIZATION; CELL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; DECIDUA; DECIDUALIZATION; EMBRYO; ENDOCYTOSIS; ENDOSOME; FIRST TRIMESTER PREGNANCY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; UPREGULATION; VASCULARIZATION;

EID: 31144460282     PISSN: 15457885     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.0040009     Document Type: Article

References (74)

1. Moretta L, Moretta A (2004) Unravelling natural killer cell function: Triggering and inhibitory human NK receptors. EMBO J 23: 255-259.
2. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23: 225-274.
3. Cerwenka A, Lanier LL (2001) Natural killer cells, viruses, and cancer. Nat Rev Immunol 1: 41-49.
4. Gasser S, Orsulic S, Brown EJ, Raulet DH (2005) The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190.
5. Moffett-King A (2002) Natural killer cells and pregnancy. Nat Rev Immunol 2: 656-663.
6. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati M, et al. (1995) Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains. Immunity 2: 439-449.
7. Rajagopalan S, Fu J, Long EO (2001) Cutting edge: Induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 167: 1877-1881.
8. Rajagopalan S, Long EO (1999) A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells [published erratum appears in J Exp Med 2000;191:2027]. J Exp Med 189: 1093-1100.
9. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, et al. (1999) Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A 96: 5674-5679.
10. Vilches C, Parham P (2002) KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20: 217-251.
11. Parham P (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5: 201-214.
12. Stewart CA,Van Bergen J, Trowsdale J (2003) Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J Immunol 170: 6073-6081.
13. Witt CS, Whiteway JM, Warren HS, Barden A, Rogers M, et al. (2002) Alleles of the KIR2DL4 receptor and their lack of association with pre-eclampsia. Eur J Immunol 32: 18-29.
14. Goodridge JP, Witt CS, Christiansen FT, Warren HS (2003) KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol 171: 1768-1774.
15. Kikuchi-Maki A, Catina TL, Campbell KS (2005) Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein. J Immunol 174: 3859-3863.
16. Faure M, Long EO (2002) KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol 168: 6208-6214.
17. Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS (2003) KIR2DL4 is an IL2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 171: 3415-3425.
18. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, et al. (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science 248: 220-223.
19. LeMaoult J, Le Discorde M, Rouas-Freiss N, Moreau P, Menier C, et al. (2003) Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 62: 273-284.
20. Trundley A, Moffett A (2004) Human uterine leukocytes and pregnancy. Tissue Antigens 63: 1-12.
21. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, et al. (2003) Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 171: 1376-1384.
22. Bainbridge D, Ellis S, Le Bouteiller P, Sargent I (2001) HLA-G remains a mystery. Immunol Today 22: 548-552.
23. Carosella ED, Dausset J, Rouas-Freiss N (1999) Immunotolerant functions of HLA-G. Cell Mol Life Sci 55: 327-333.
24. Avril T, Jarousseau AC, Watier H, Boucraut J, Le Bouteiller P, et al. (1999) Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. J Immunol 162: 5902-5909.
25. Loke YW, King A (2000) Decidual natural-killer-cell interaction with trophoblast: Cytolysis or cytokine production? Biochem Soc Trans 28: 196-198.
26. Parham P (2004) NK cells and trophoblasts: Partners in pregnancy. J Exp Med 200: 951-955.
27. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CWG, Carrington M, et al. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200: 957-965.
28. Croy BA, Esadeg S, Chantakru S, Van den Heuvel M, Paffaro VAJ, et al. (2003) Update on pathways regulating the activation of uterine natural killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J Reprod Immunol 59: 175-191.
29. van der Meer A, Lukassen HG, van Lierop MJ, Wijnands F, Mosselman S, et al. (2004) Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells. Mol Hum Reprod 10: 189-195.
30. Croy BA, He H, Esadeg S, Wei QX, McCartney D, et al. (2003) Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling. Reproduction 126: 149-160.
31. Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422: 37-44.
32. van der Bliek AM, Redelmeier TE, Damke H, Tisdale EJ, Meyerowitz EM, et al. (1993) Mutations in human dynamin block an intermediate stage in coated vesicle formation. J Cell Biol 122: 553-563.
33. Catalfamo M, Karpova T, McNally J, Costes SV, Lockett SJ, et al. (2004) Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 20: 219-230.
34. de Renzis S, Sonnichsen B, Zerial M (2002) Divalent Rab effectors regulate the sub-compartmental organization and sorting of early endosomes. Nat Cell Biol 4: 124-133.
35. Boyson JE, Erskine R, Whitman MC, Chiu M, Lau JM, et al. (2002) Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci U S A 99: 16180-16185.
36. Allan DSJ, Colonna M, Lanier LL, Churakova TD, Abrams JS, et al. (1999) Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med 189: 1149-1155.
37. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N (1998) Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 161: 571-577.
38. Valés-Gómez M, Erskine RA, Deacon MP, Strominger JL, Reyburn HT (2001) The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins. Proc Natl Acad Sci U S A 98: 1734-1739.
39. D'Andrea A, Chang C, Phillips JH, Lanier LL (1996) Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J Exp Med 184: 789-794.
40. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD (2000) Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543.
41. Fujii T, Ishitani A, Geraghty DE (1994) A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 153: 5516-5524.
42. Park GM, Lee S, Park B, Kim E, Shin J, et al. (2004) Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun 313: 606-611.
43. Van Lierop MJ, Wijnands F, Loke YW, Emmer PM, Lukassen HG, et al. (2002) Detection of HLA-G by a specific sandwich ELISA using monoclonal antibodies G233 and 56B. Mol Hum Reprod 8: 776-784.
44. Yang H, Young DW, Gusovsky F, Chow JC (2000) Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 275: 20861-20866.
45. Miaczynska M, Pelkmans L, Zerial M (2004) Not just a sink: Endosomes in control of signal transduction. Curr Opin Cell Biol 16: 400-406.
46. Takeshita F, Gursel I, Ishii KJ, Suzuki K, Gursel M, et al. (2004) Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin Immunol 16: 17-22.
47. Vieira AV, Lamaze C, Schmid SL (1996) Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274: 2086-2089.
48. MacKinnon R (2005) Membrane protein insertion and stability. Science 307: 1425-1426.
49. Menier C, Riteau B, Dausset J, Carosella ED, Rouas-Freiss N (2000) HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol 61: 1118-1125.
50. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, et al. (2000) Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164: 6100-6104.
51. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED (2001) Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the alloproliferative response: A CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 98: 12150-12155.
52. Mellor AL, Munn DH (2000) Immunology at the maternal-fetal interface: Lessons for T cell tolerance and suppression. Annu Rev Immunol 18: 367-391.
53. Moffett A, Loke YW (2004) The immunological paradox of pregnancy: A reappraisal. Placenta 25: 1-8.
54. Navarro F, Llano M, Bellon T, Colonna M, Geraghty DE, et al. (1999) The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 29: 277-283.
55. Mellor AL, Munn DH (2001) Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J Reprod Immunol 52: 5-13.
56. Golos TG (2003) Nonhuman primate placental MHC expression: A model for exploring mechanisms of human maternal-fetal immune tolerance. Hum Immunol 64: 1102-1109.
57. Jackson MR, Carney EW, Lye SJ, Ritchie JW (1994) Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 15: 341-353.
58. Choi SJ, Park JY, Lee YK, Choi HI, Lee YS, et al. (2002) Effects of cytokines on VEGF expression and secretion by human first trimester trophoblast cell line. Am J Reprod Immunol 48: 70-76.
59. Matsumoto H, Ma WG, Daikoku T, Zhao X, Paria BC, et al. (2002) Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice. J Biol Chem 277: 29260-29267.
60. Lane BR, Liu J, Bock PJ, Schols D, Coffey MJ, et al. (2002) Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma. J Virol 76: 11570-11583.
61. Sparmann A, Bar-Sagi D (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6: 447-458.
62. Zhang JH, He H, Borzychowski AM, Takeda K, Akira S, et al. (2003) Analysis of cytokine regulators inducing interferon production by mouse uterine natural killer cells. Biol Reprod 69: 404-411.
63. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, et al. (2002) HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 32: 311-315.
64. Yie SM, Balakier H, Motamedi G, Librach CL (2005) Secretion of human leukocyte antigen-G by human embryos is associated with a higher in vitro fertilization pregnancy rate. Fertil Steril 83: 30-36.
65. Yie SM, Taylor RN, Librach C (2005) Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 193: 204-208.
66. Menier C, Rabreau M, Challier JC, Le Discorde M, Carosella ED, et al. (2004) Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoeeisis. Blood 104: 3153-3160.
67. Lee N, Malacko AR, Ishitani A, Chen MC, Bajorath J, et al. (1995) The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3: 591-600.
68. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, et al. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661-671.
69. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO (1995) Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3: 801-809.
70. Sonnichsen B, De Renzis S, Nielsen E, Rietdorf J, Zerial M (2000) Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11. J Cell Biol 149: 901-914.
71. Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, et al. (2005) Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105: 4722-4729.
72. Rojo S, Burshtyn DN, Long EO, Wagtmann N (1997) Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells. J Immunol 158: 9-12.
73. Strong RK, Holmes MA, Li P, Braun L, Lee N, et al. (2003) HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 278: 5082-5090.
74. Winter CC, Long EO (2000) Binding of soluble KIR-Fc fusion proteins to HLA class I. In: Campbell KS, Colonna M, editors. Natural Killer Cell Protocols. Totowa (New Jersey): Humana Press. pp. 239-250.